SAS Clinical Interview Question & Answers : What is Clinical Early Phase ?
In this video, we'll be discussing another common interview question in the field of clinical research: What is Clinical Early Phase? Clinical Early Phase refers to the first phase of clinical development in which a new drug or medical device is tested in humans for the first time.
This phase is also known as First-in-Human (FIH) studies and typically involves a small number of healthy volunteers or patients with the target disease. The main goal of Clinical Early Phase studies is to assess the safety, tolerability, and pharmacokinetics of the new drug or medical device.
Clinical Early Phase studies are highly regulated by international guidelines and require close monitoring of the participants for adverse events and side effects. These studies also involve a variety of tests and assessments to evaluate the drug's effects on the body, including pharmacokinetic and pharmacodynamic analyses.
In this video, we'll provide you with a comprehensive overview of Clinical Early Phase, including its importance in drug development, different types of early phase studies, and common challenges and limitations associated with this phase.
Whether you're a student, a clinical research professional, or simply interested in learning more about Clinical Early Phase, this video will provide you with valuable insights and practical knowledge to help you prepare for your SAS Clinical Interview.